Digital health startup AESOP Technology has raised $2.95 million in a series pre-A funding round.
AESOP uses artificial intelligence to detect medical billing errors. AESOP was initially based in Taiwan but is now headquartered in San Francisco. The funding will be used to expand AESOP's presence in the U.S. market, according to an Aug. 31 AESOP news release.
AESOP was originally founded as RxPrime and worked to detect drug prescription look-alike and sound-alike errors.
Taiwania Capital led the funding round with participation from Colopl Next, 500 Startups and BE Capital.